https://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 04:38:12 +0200Wed, 10 Jul 2024 17:50:18 +0200https://www.ema.europa.eu/en/medicines/human/EPAR/fruzaqlaHuman medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation: 20/06/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/fruzaqlaWed, 10 Jul 2024 17:50:18 +0200Human medicinehttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5979-en.pdfFruzaqla : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5979-en.pdfWed, 10 Jul 2024 17:30:00 +0200Human medicine